|
OVID Ovid Therapeutics Inc 1636651 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-16,988,000.00 |
| Balance Sheet |
|
Current Assets
|
$160,145,000.00 |
|
Assets
|
$225,628,000.00 |
|
Current Liabilities
|
$15,748,000.00 |
|
Liabilities
|
$27,359,000.00 |
|
Equity
|
$198,269,000.00 |
|
Shares Out
|
167266466.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,899,000.00 |
|
Investing Cash Flow
|
$5,950,000.00 |
| Market Analysis |
Market Cap
|
$396,421,524.42 |
|
Price
|
$2.31 |
|
BVPS
|
1.19 |
|
PB
|
1.99 |
|
EPS
|
-0.20 |
|
FCF
|
$-13,899,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-18 |
0.06 |
|
|
2026-05-12 |
-0.12 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.06 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.17 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OVID documents filed with the SEC.
OVID Filings
Clear
